This Workshop features thought leaders in our genetics community who will describe current and potential future large-scale collaborative initiatives to advance Canadian genomics. The CCMG is well positioned to bring together genetics health professionals, researchers, policymakers, and funders to coordinate national efforts. Attendees are asked to be active participants in a discussion about the need for, and key components of, a genomic medicine strategy for Canada as a whole.

At the end of the session, participants will be able to:

  • List examples of current pan-Canadian data-sharing initiatives and collaborative projects.
  • Summarize strengths, weaknesses, and opportunities related to such initiatives.
  • Evaluate the need for a uniquely Canadian strategy for genomic medicine.

Speakers:

Dr. Linlea Armstrong
Dr. Jordan Lerner-Ellis
Dr. Kym Boycott

Target Audience: Geneticists, Trainees, Policy makers, researchers

CanMEDS Roles: Medical Expert (the integrating role), Communicator, Collaborator, Leader, Health Advocate, Scholar, Professional

Dr. Linlea Armstrong

Linlea holds the interrelated roles of Medical Director of BC’s Provincial Medical Genetics Program (PMGP) and Associate Head, Clinical of UBC’s Department of Medical Genetics. She is involved in the leadership of Genome Sequencing BC, and on the province’s Expensive Drugs for Rare Disease Advisory. Her work is informed by collaborations over the years with researchers and past directorships of Vancouver Fraser Medical Program Faculty Development and UBC Medical Genetics Residency Program. With increasingly accessible and powerful genomic testing and rapid expansions in informed treatments, Linlea and colleagues in PMGP are updating and optimizing internal practices and prioritizing building external collaborations to optimize care pathways. Linlea wishes to recognize with gratitude the innovative ways her outstanding colleagues have been carving out components of the complex pathways for improvements, and finding resources to advance genomic informed provider capacity in BC.

Dr Jordan Lerner-Ellis is a Clinical Molecular Geneticist and Laboratory Director at Mount Sinai Hospital, Associate Professor at the University of Toronto and Scientist at the Lunenfeld-Tanenbaum Research Institute. His research interests include developing digital technologies and infrastructure to support greater national collaboration, provide advanced analytical tools, overcome barriers to data sharing, and ensure constant improvement in both the scientific quality and clinical applications of genetic data for the purpose of understanding the relationship between genes and disease.

Declaration of Conflict of Interest: Receives honoraria from Mount Sinai Hospital, and Alberta Health Services. Receives Funded grants from PI and or co-PI CFI, CIHR.

Kym Boycott, M.D., Ph.D., FRCPC, FCCMG, is a Professor of Pediatrics at the University of Ottawa in Canada, where she is a clinical geneticist at the Children’s Hospital of Eastern Ontario (CHEO), Chair of the Department of Genetics, and a Senior Scientist at the CHEO Research Institute. Prof. Boycott is a Tier 1 Canada Research Chair in Rare Disease Precision Health whose research program bridges clinical genomics to basic research and is focused on understanding the molecular pathogenesis of rare diseases to improve patient care and family well-being. She leads several national initiatives including the Care4Rare Canada Consortium, established in 2010, integrating genomic and other ‘omics technologies to improve our understanding of rare diseases, focusing on solving the unsolved and most difficult rare diseases.

Event Timeslots (2)

Day 2
-
Part 1 - accredited

Day 2
-
Part 2 - accredited